$85.00 Purchase & earn 85 points
Chromatographic separation was conducted on a Brownlee SPP C18 column (2.1 mm 75 mm, 2.7 m particle size, Perkin Elmer, Waltham, MA) using mobile phase A (100% H2O containing 0.1% formic acid and 1% of 1 M NH 4 OAc) and B (1:1 acetonitrile:isopropanol containing 0.1% formic acid and 1% of 1 M NH 4 OAc)
Novo Nordisks internal communications, safety databases, and regulatory submissions contain the evidence needed to prove knowledge of gastroparesis and NAION risks, but extracting and presenting this information requires legal teams with experience handling massive pharmaceutical discovery
doi: 10.1016/j.cpt.2025.02.006 67 AliSSAl-TohamyRAl-ZahraniMBadrASunJ
Case 2: Pharmaceutical Research Company Challenge : A biotech firm researching wound-healing therapies required ultra-pure GHK-Cu with full impurity profiles and endotoxin testing for their pre-clinical studies
10.1002/mnfr.201500634 Mol